He holds a Canada Research Chair in Regulatory Peptides and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology.

His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and studies the molecular biology and physiology of the glucagon-like peptides.